Tag Archives: CMCT

Top 5 Undervalued Stocks To Own Right Now

How Trump’s Tax Act Could Affect Annuity Issuers

5 Big Questions About Life Insurance for 2018

How to Lean Against the Biases in 2018

Trinity Place Holdings Inc. has closed on $189.5 million in construction financing for its new 300,000-square-foot mixed-use development at 77 Greenwich St. in Lower Manhattan, in New York City.

The project calls for the construction of an approximately 500-foot tall tower building that will contain 90 luxury condominium units, the adaptive reuse of the landmarked Robert and Anne Dickey House, 7,500 square feet of street level retail space, and construction of a new wheelchair-accessible subway entrance on Trinity Place.

The construction loan has a four-year term with one extension option. The loan, in addition to equity already funded by Trinity Place and future contributions by the New York City School Construction Authority, will cover anticipated future costs of the project. The project hard costs are 93% “bought out” and are managed under a gross maximum price construction contract, Trinity Place reports. In its press announcement, Trinity did not provide any further financial details of the transaction, including the identity of the lender.

Top 5 Undervalued Stocks To Own Right Now: Ecolab Inc.(ECL)

Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31.

In 2015, we took several actions to continue to invest in and build our business, including: the June 2015 acquisition of Jianghai Environmental Protection Co. Ltd, an industrial water treatment company headquartered in Changzhou, China; the November 2015 acquisition of the U.S. operations of Charlotte, N.C. – based Swisher Hygiene Inc, a provider of hygiene and sanitizing solutions for the foodservice, hospitality, retail and healthcare markets; and the November 2015 acquisition of the assets and operations of Calgary – based Ultra Fab Industries Ltd, which manufactures customized solutions and specialized chemical injection systems for the oil and gas industry. See Part II, Item 8, Note 4 of this Form 10-K for additional information about these three acquisitions as well as additional actions taken by the Company.   Advisors’ Opinion:

  • [By Ethan Ryder]

    TRADEMARK VIOLATION WARNING: “Ecolab (ECL) Sets New 52-Week High at $173.40” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at www.tickerreport.com/banking-finance/4218879/ecolab-ecl-sets-new-52-week-high-at-173-40.html.

  • [By Maxx Chatsko]

    Last year,Ecolab (NYSE:ECL) had to navigate headwinds including global currency fluctuations made worse by a strong U.S. dollar, rising delivery costs, and volatility in energy markets. The business attempted to offset cost increases by improving operating efficiency and increasing selling prices, but those efforts weren’t enough to stop fourth-quarter operating income from sliding 4% compared to 2017. Revenue increased 3% year over year.

  • [By Motley Fool Transcription]

    Ecolab Inc. (NYSE:ECL)Q4 2018 Earnings Conference CallFebruary 19, 2019, 1:00 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


Top 5 Undervalued Stocks To Own Right Now: CIM Commercial Trust Corporation(CMCT)

CIM Commercial Trust Corporation (CIM Commercial), incorporated on April 25, 2014, is engaged in acquiring, owning and operating Class A office investments in urban communities throughout the United States. These communities are located in areas that include traditional downtown areas and suburban main streets. The Company operates in the business segments, including the acquisition, redevelopment, ownership and management of office real estate, multifamily real estate and hotels. The Company’s real estate portfolio consists of approximately 30 assets, all of which are fee-simple properties except one leasehold property. It has approximately 20 office properties (including over two parking garages, one of which has street level retail space, and over two development sites, one of which is being used as a parking lot), totaling approximately 5.6 million rentable square feet, which are approximately 86.9% occupied; multifamily properties, composed of over 930 units, which are approximately 92.4% occupied, and hotels, which have a total of approximately 1,070 rooms. Its office, multifamily and hotel assets are located in over 10 of the United States markets. The Company is managed by affiliates of CIM Group, L.P. (CIM Group or CIM).

The Company seeks risk adjusted returns by utilizing the CIM platform. The Company invests primarily in substantially stabilized real estate and real estate related assets located in areas that CIM has targeted for opportunistic investment. CIM targets investments in diverse types of real estate assets, including office, retail, for rent and for sale multifamily residential, hotel, parking, and signage through CIM’s network and its opportunistic investment activities.

Advisors’ Opinion:

  • [By Logan Wallace]

    Crowd Machine (CURRENCY:CMCT) traded down 3.1% against the U.S. dollar during the 1-day period ending at 18:00 PM ET on February 2nd. One Crowd Machine token can currently be bought for approximately $0.0023 or 0.00000066 BTC on major cryptocurrency exchanges including Bancor Network, BitForex, Bittrex and HitBTC. During the last seven days, Crowd Machine has traded down 41.4% against the U.S. dollar. Crowd Machine has a total market capitalization of $1.09 million and approximately $553,701.00 worth of Crowd Machine was traded on exchanges in the last day.

  • [By Shane Hupp]

    CIM Commercial Trust (NASDAQ:CMCT) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Joseph Griffin]

    Crowd Machine (CURRENCY:CMCT) traded 9.6% lower against the US dollar during the 24-hour period ending at 0:00 AM ET on May 14th. Over the last week, Crowd Machine has traded down 49% against the US dollar. One Crowd Machine token can now be bought for approximately $0.0436 or 0.00000499 BTC on exchanges including Coinhub, BitForex and HitBTC. Crowd Machine has a market capitalization of $0.00 and $233,116.00 worth of Crowd Machine was traded on exchanges in the last 24 hours.

  • [By Jack Delaney]

    CIM Commercial Trust Corp. (NYSE: CMCT) acquires, owns, and operates office properties in the United States.

    It has a portfolio of more than 100 buildings that is valued at a combined $25 billion, according to BizJournals.com.

Top 5 Undervalued Stocks To Own Right Now: Pagegroup PLC (PAGE)

PageGroup plc, formerly Michael Page International plc, is a United Kingdom-based recruitment consultancy. The Company’s segments include EMEA, United Kingdom, Asia Pacific and Americas. The Company is organized into three brands operating at different levels of the market: Michael Page, Page Personnel and Page Executive. Page Executive offers executive search services. Page Executive provides a range of search, selection and management solutions for organizations on a permanent and interim basis. Michael Page recruits on a permanent, temporary, contract, and interim basis from second/third job levels upward. Page Personnel offer specialist recruitment services to organizations requiring permanent employees or temporary or contract staff at technical and administrative support, professional clerical and junior management levels. The Company provides specialist services to organizations requiring talent at the professional clerical and support levels. Advisors’ Opinion:

  • [By Shane Hupp]

    Pagegroup (LON:PAGE) had its target price cut by equities researchers at Jefferies Financial Group from GBX 610 ($7.97) to GBX 590 ($7.71) in a note issued to investors on Tuesday, ThisIsMoney.Co.Uk reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s price objective suggests a potential upside of 10.90% from the stock’s previous close.

  • [By Joseph Griffin]

    Pagegroup (LON:PAGE) had its target price reduced by Royal Bank of Canada from GBX 670 ($8.75) to GBX 620 ($8.10) in a note issued to investors on Monday. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would indicate a potential upside of 30.86% from the stock’s current price.

Top 5 Undervalued Stocks To Own Right Now: Fiserv, Inc.(FISV)

Fiserv, Inc. is a leading global provider of financial services technology. We are publicly traded on the NASDAQ Global Select Market and part of the S&P 500 Index. We serve approximately 14,500 clients worldwide, including banks, thrifts, credit unions, investment management firms, leasing and finance companies, retailers, and merchants. We provide account processing systems; electronic payments processing products and services, such as electronic bill payment and presentment services, card-based transaction processing and network services, ACH transaction processing, account-to-account transfers, and person-to-person payments; internet and mobile banking systems; and related services including document and payment card production and distribution, check processing and imaging, source capture systems, and lending and risk management products and services.   Advisors’ Opinion:

  • [By Billy Duberstein]

    In particular, Palmer worries about Fiserv’s (NASDAQ:FISV)recent acquisition of First Data (NYSE:FDC). First Data makes the Clover point-of-sale system, a Square competitor. The combined companies say they intend to spend over $500 million over five years to “accelerate growth,” which likely means putting serious weight behind Clover.

  • [By Shane Hupp]

    Fiserv (NASDAQ:FISV) last released its quarterly earnings data on Thursday, February 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.84. Fiserv had a return on equity of 47.56% and a net margin of 20.39%. The business had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the firm posted $0.71 EPS. The business’s revenue for the quarter was up 2.3% compared to the same quarter last year. Equities analysts expect that Fiserv Inc will post 3.46 EPS for the current fiscal year.

    ILLEGAL ACTIVITY NOTICE: “Checchi Capital Advisers LLC Has $581,000 Position in Fiserv Inc (FISV)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4163064/checchi-capital-advisers-llc-has-581000-position-in-fiserv-inc-fisv.html.

    Fiserv Profile

  • [By Max Byerly]

    Cerity Partners LLC reduced its stake in Fiserv Inc (NASDAQ:FISV) by 0.5% during the fourth quarter, HoldingsChannel reports. The firm owned 27,751 shares of the business services provider’s stock after selling 139 shares during the quarter. Cerity Partners LLC’s holdings in Fiserv were worth $2,039,000 as of its most recent SEC filing.

Top 5 Undervalued Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products to meet unmet medical needs. The company markets Xyrem, a sodium oxybate oral solution for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; and Luvox CR extended-release capsules for the treatment of obsessive compulsive disorder. Its product candidates under clinical development include JZP-6, a Phase III pivotal clinical trials completed product for the treatment of fibromyalgia; and JZP-8, an intranasal formulation of clonazepam, which has completed Phase II clinical trial for the treatment of acute repetitive seizures in epilepsy and solid oral dosage forms of sodium oxybate. The company sells its products through specialty sales force targeting sleep specialists, psychiatrists, neurologists, and pulmonologists. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headq uartered in Palo Alto, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Matthew P. Young Sells 1,152 Shares of Jazz Pharmaceuticals PLC (JAZZ) Stock” was first reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at www.tickerreport.com/banking-finance/4204759/matthew-p-young-sells-1152-shares-of-jazz-pharmaceuticals-plc-jazz-stock.html.

  • [By Keith Speights]

    The three best biotech bargains on the market right now based on PEG ratios are Celgene (NASDAQ:CELG), Exelixis (NASDAQ:EXEL), and Jazz Pharmaceuticals (NASDAQ:JAZZ). Here’s why these biotech stocks are priced attractively.